Detalles de la búsqueda
1.
Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer.
Cell;
157(5): 1088-103, 2014 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-24855946
2.
Novel two-tiered screening approach identifies synergistic combinations of natural compounds for prostate cancer prevention and treatment.
Mol Carcinog;
63(4): 589-600, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38197430
3.
Enzyme-mediated depletion of serum l-Met abrogates prostate cancer growth via multiple mechanisms without evidence of systemic toxicity.
Proc Natl Acad Sci U S A;
117(23): 13000-13011, 2020 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32434918
4.
The low molecular weight protein tyrosine phosphatase promotes adipogenesis and subcutaneous adipocyte hypertrophy.
J Cell Physiol;
236(9): 6630-6642, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33615467
5.
Novel Strategy for Untargeted Chiral Metabolomics using Liquid Chromatography-High Resolution Tandem Mass Spectrometry.
Anal Chem;
93(14): 5805-5814, 2021 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818082
6.
Automated Trimethyl Sulfonium Hydroxide Derivatization Method for High-Throughput Fatty Acid Profiling by Gas Chromatography-Mass Spectrometry.
Molecules;
26(20)2021 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34684827
7.
Identification of a synergistic combination of dimethylaminoparthenolide and shikonin alters metabolism and inhibits proliferation of pediatric precursor-B cell acute lymphoblastic leukemia.
Mol Carcinog;
59(4): 399-411, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32027051
8.
Metabolomic signature of brain cancer.
Mol Carcinog;
56(11): 2355-2371, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28618012
9.
MR-detectable metabolic consequences of mitogen-activated protein kinase kinase (MEK) inhibition.
NMR Biomed;
27(6): 700-8, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24706368
10.
HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.
NMR Biomed;
27(11): 1361-70, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25199993
11.
Targeting prostate tumor low-molecular weight tyrosine phosphatase for oxidation-sensitizing therapy.
Sci Adv;
10(5): eadg7887, 2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38295166
12.
Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells.
NMR Biomed;
26(3): 299-306, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22945392
13.
Generation of a Yeast Cell Model Potentially Useful to Identify the Mammalian Mitochondrial N-Acetylglutamate Transporter.
Biomolecules;
13(5)2023 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37238678
14.
Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer.
Cancer Res;
83(1): 59-73, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36265133
15.
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses.
Res Sq;
2023 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36865338
16.
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials.
Nat Med;
29(1): 115-126, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36658425
17.
Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide.
Front Oncol;
12: 900082, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36226069
18.
Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry.
iScience;
25(5): 104221, 2022 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35494234
19.
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Signal Transduct Target Ther;
7(1): 51, 2022 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35185150
20.
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.
Nat Commun;
13(1): 2801, 2022 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35589701